Figure 5.

Insoluble particulates after heating (36–37 °C) (× 400). These particulates were produced from betamethasone sodium phosphate (BSP) mixed with 0.75% ropivacaine HCl (ropivacaine).

Insoluble particulates after heating (36–37 °C) (× 400). These particulates were produced from betamethasone sodium phosphate (BSP) mixed with 0.75% ropivacaine HCl (ropivacaine).